Independent report

Priority groups for coronavirus (COVID-19) vaccination: advice from the JCVI, 30 December 2020

Advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the groups that should be prioritised for vaccination.

• From: Department of Health and Social Care
• Published: 30 December 2020
• Last updated: 6 January 2021
  Show all updates

  1. 6 January 2021

     Update to footnote 2: the Pfizer-BioNTech vaccine is authorised in those aged 16 years and over. The AstraZeneca vaccine is only authorised for use in those aged 18 years and over.

  2. 30 December 2020

     First published.

Documents

Joint Committee on Vaccination and Immunisation: advice on priority groups for COVID-19 vaccination, 30 December 2020

HTML

Annex A: COVID-19 vaccine and health inequalities: considerations for prioritisation and implementation

HTML

Joint Committee on Vaccination and Immunisation: advice on priority groups for COVID-19 vaccination, 30 December 2020

PDF, 219 KB, 16 pages

Details

This advice is provided to facilitate the development of policy on COVID-19 vaccination in the UK.